NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AMC Networks Inc. (NASDAQ:AMCX), JELD-WEN Holding, Inc. (NYSE:JELD), Blueprint Medicines Corporation (NASDAQ:BPMC), Northwest Bancshares, Inc. (NASDAQ:NWBI), Anika Therapeutics Inc. (NASDAQ:ANIK), and Aethlon Medical, Inc. (NASDAQ:AEMD), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AMCX DOWNLOAD: http://Fundamental-Markets.com/register/?so=AMCX
JELD DOWNLOAD:
http://Fundamental-Markets.com/register/?so=JELD
BPMC DOWNLOAD:
http://Fundamental-Markets.com/register/?so=BPMC
NWBI DOWNLOAD:
http://Fundamental-Markets.com/register/?so=NWBI
ANIK DOWNLOAD:
http://Fundamental-Markets.com/register/?so=ANIK
AEMD DOWNLOAD:
http://Fundamental-Markets.com/register/?so=AEMD

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine AMC Networks Inc. (NASDAQ:AMCX), JELD-WEN Holding, Inc. (NYSE:JELD), Blueprint Medicines Corporation (NASDAQ:BPMC), Northwest Bancshares, Inc. (NASDAQ:NWBI), Anika Therapeutics Inc. (NASDAQ:ANIK), and Aethlon Medical, Inc. (NASDAQ:AEMD) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 27th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

AMC NETWORKS INC. (AMCX) REPORT OVERVIEW

AMC Networks' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, AMC Networks reported revenue of $726.93MM vs $729.60MM (down 0.36%) and basic earnings per share $2.34 vs $0.24 (up 875.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, AMC Networks reported revenue of $2,805.69MM vs $2,755.65MM (up 1.82%) and basic earnings per share $7.26 vs $3.77 (up 92.57%). AMC Networks is expected to report earnings on May 10th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $2.10. The estimated EPS forecast for the next fiscal year is $8.88 and is expected to report on March 7th, 2019.

To read the full AMC Networks Inc. (AMCX) report, download it here: http://Fundamental-Markets.com/register/?so=AMCX

-----------------------------------------

JELD-WEN HOLDING, INC. (JELD) REPORT OVERVIEW

JELD-WEN Holding's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, JELD-WEN Holding reported revenue of $976.00MM vs $973.17MM (up 0.29%) and basic earnings per share -$0.89 vs -$1.69. For the twelve months ended December 31st, 2017 vs December 31st, 2016, JELD-WEN Holding reported revenue of $3,763.93MM vs $3,666.80MM (up 2.65%) and basic earnings per share $0.00 vs -$1.08. JELD-WEN Holding is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.05. The estimated EPS forecast for the next fiscal year is $2.74 and is expected to report on February 20th, 2019.

To read the full JELD-WEN Holding, Inc. (JELD) report, download it here: http://Fundamental-Markets.com/register/?so=JELD

-----------------------------------------

BLUEPRINT MEDICINES CORPORATION (BPMC) REPORT OVERVIEW

Blueprint Medicines' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Blueprint Medicines reported revenue of $1.63MM vs $7.69MM (down 78.83%) and basic earnings per share -$1.26 vs -$0.75. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Blueprint Medicines reported revenue of $21.43MM vs $27.77MM (down 22.85%) and basic earnings per share -$3.92 vs -$2.64. Blueprint Medicines is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.84. The estimated EPS forecast for the next fiscal year is -$5.36 and is expected to report on February 20th, 2019.

To read the full Blueprint Medicines Corporation (BPMC) report, download it here: http://Fundamental-Markets.com/register/?so=BPMC

-----------------------------------------

NORTHWEST BANCSHARES, INC. (NWBI) REPORT OVERVIEW

Northwest Bancshares' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Northwest Bancshares reported interest income of $89.53MM vs $87.27MM (up 2.60%) and basic earnings per share $0.25 vs $0.18 (up 38.89%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Northwest Bancshares reported interest income of $358.86MM vs $345.63MM (up 3.83%) and basic earnings per share $0.94 vs $0.50 (up 88.00%). Northwest Bancshares is expected to report earnings on July 23rd, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.22. The estimated EPS forecast for the next fiscal year is $1.01 and is expected to report on January 28th, 2019.

To read the full Northwest Bancshares, Inc. (NWBI) report, download it here: http://Fundamental-Markets.com/register/?so=NWBI

-----------------------------------------

ANIKA THERAPEUTICS INC. (ANIK) REPORT OVERVIEW

Anika Therapeutics' Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Anika Therapeutics reported revenue of $29.39MM vs $28.73MM (up 2.30%) and basic earnings per share $0.55 vs $0.56 (down 1.79%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Anika Therapeutics reported revenue of $113.42MM vs $103.38MM (up 9.71%) and basic earnings per share $2.18 vs $2.22 (down 1.80%). Anika Therapeutics is expected to report earnings on May 2nd, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.37. The estimated EPS forecast for the next fiscal year is $1.66 and is expected to report on February 20th, 2019.

To read the full Anika Therapeutics Inc. (ANIK) report, download it here: http://Fundamental-Markets.com/register/?so=ANIK

-----------------------------------------

AETHLON MEDICAL, INC. (AEMD) REPORT OVERVIEW

Aethlon Medical's Recent Financial Performance

For the three months ended December 31st, 2017 vs December 31st, 2016, Aethlon Medical reported revenue of $0.07MM vs $0.00MM and basic earnings per share -$0.08 vs -$0.15. For the twelve months ended March 31st, 2017 vs March 31st, 2016, Aethlon Medical reported revenue of $0.39MM vs $0.89MM (down 55.77%) and basic earnings per share -$0.94 vs -$0.66. Aethlon Medical is expected to report earnings on June 27th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.22.

To read the full Aethlon Medical, Inc. (AEMD) report, download it here: http://Fundamental-Markets.com/register/?so=AEMD

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.